Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Current Assets (2023 - 2025)

Guardian Pharmacy Services' Current Assets history spans 3 years, with the latest figure at $221.6 million for Q4 2025.

  • For Q4 2025, Current Assets rose 45.83% year-over-year to $221.6 million; the TTM value through Dec 2025 reached $221.6 million, up 45.83%, while the annual FY2025 figure was $221.6 million, 45.83% up from the prior year.
  • Current Assets for Q4 2025 was $221.6 million at Guardian Pharmacy Services, up from $198.3 million in the prior quarter.
  • Across five years, Current Assets topped out at $221.6 million in Q4 2025 and bottomed at $129.6 million in Q4 2023.
  • The 3-year median for Current Assets is $170.5 million (2025), against an average of $174.0 million.
  • The largest YoY upside for Current Assets was 45.83% in 2025 against a maximum downside of 9.99% in 2025.
  • A 3-year view of Current Assets shows it stood at $129.6 million in 2023, then grew by 17.27% to $152.0 million in 2024, then skyrocketed by 45.83% to $221.6 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Current Assets are $221.6 million (Q4 2025), $198.3 million (Q3 2025), and $170.5 million (Q2 2025).